查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379083

經皮給藥系統市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Transdermal Drug Delivery Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球經皮給藥系統市場規模達到63億美元。展望未來， IMARC Group預計到2028年市場規模將達到92億美元，2022-2028年複合年成長率（CAGR）為6.5%。

經皮給藥系統（TDDS）是一種透過皮膚輸送藥物進行全身分佈的替代系統。它被用作口腔血管內、皮下和跨黏膜途徑的替代方案。 TDDS 可支援慢性和急性疾病以及美容手術，因為它可以透過皮膚輸送藥物和藥妝品等生物活性劑。它提供藥物的受控釋放，從而減少首過代謝效應，減少副作用，並透過在整個治療過程中實現穩定的血液藥物分佈來提高劑量的療效。

經皮給藥系統市場趨勢：

全球經皮給藥系統市場的主要促進因素是無法透過傳統給藥系統（例如口服藥物）治療的慢性疾病病例不斷增加。患有糖尿病等長期疾病的患者正在轉向自行用藥。因此，人們引入了黏性皮膚貼片，以在沒有疼痛的情況下進行日常用藥。這鼓勵患者和醫生更喜歡無痛給藥系統。除此之外，離子電滲療法等第三代經皮給藥系統的廣泛採用可以促進患者的自力更生，因為它減少了頻繁去醫院的次數並減少了累積的治療費用。此外，技術進步，例如微針的加入、經皮貼片設計的修改以及壓敏黏合劑和滲透促進劑的加入，為製造商提供了巨大的機會。

本報告回答的關鍵問題：

  • 迄今為止，全球經皮給藥系統市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球經皮給藥系統市場有何影響？
  • 主要區域市場有哪些？
  • 基於技術的市場區隔是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球經皮給藥系統市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球經皮給藥系統市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依科技分類的市場

  • 電穿孔
    • 市場走向
    • 市場預測
  • 無線電頻率
    • 市場走向
    • 市場預測
  • 離子電滲透療法
    • 市場走向
    • 市場預測
  • 微孔化
    • 市場走向
    • 市場預測
  • 熱的
    • 市場走向
    • 市場預測
  • 機械陣列
    • 市場走向
    • 市場預測
  • 超音波
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按應用分類的市場區隔

  • 中樞神經系統
    • 市場走向
    • 市場預測
  • 疼痛管理
    • 市場走向
    • 市場預測
  • 心血管
    • 市場走向
    • 市場預測
  • 荷爾蒙
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • Acrux Limited
    • Boehringer Ingelheim International GmbH
    • Hisamitsu Pharmaceutical Co. Inc.
    • Lavipharm SA
    • LEAD CHEMICAL Co. Ltd.
    • Luye Pharma Group
    • Nutriband Inc.
    • Viatris Inc.
Product Code: SR112023A3983

Abstract

The global transdermal drug delivery systems market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2022-2028.

The transdermal drug delivery system (TDDS) is an alternative system of delivering drugs through the skin for systemic distribution. It is used as an alternative to oral intravascular, subcutaneous, and transmucosal routes. TDDS supports both chronic and acute diseases as well as cosmetic procedures as it delivers biologically active agents, such as drugs and cosmeceuticals, through the skin. It offers a controlled release of drugs, which reduces the first-pass metabolism effects, lessens the side effects, and improves the efficacy of the dosage by enabling a steady blood drug profile throughout the treatment.

Transdermal Drug Delivery System Market Trends:

The global transdermal drug delivery systems market is primarily driven by the growing instances of chronic disorders that cannot be treated through conventional drug delivery systems, such as oral drugs. Patients with long-term ailments, such as diabetes, are shifting toward self-administration of medicine. As a result, there has been an introduction of adhesive skin patches to administer the daily course of medication without the pain. This has encouraged patients and physicians to prefer pain-free drug delivery systems. Besides this, the wide adoption of third-generation transdermal drug delivery systems like iontophoresis promotes self-reliance in patients since it reduces frequent visits to hospitals and lessens the cumulative treatment costs. Furthermore, technological advancements, such as the inclusion of microneedles, modifications in transdermal patch designs and the incorporation of pressure-sensitive adhesives and permeation enhancers, are providing vast opportunities to manufacturers.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal drug delivery systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology and application.

Breakup by Technology:

Electroporation

Radiofrequency

Iontophoresis

Microporation

Thermal

Mechanical Arrays

Ultrasound

Others

Breakup by Application:

Central Nervous System

Pain Management

Cardiovascular

Hormone

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Acrux Limited, Boehringer Ingelheim International GmbH, Hisamitsu Pharmaceutical Co. Inc., Lavipharm S.A., LEAD CHEMICAL Co. Ltd., Luye Pharma Group, Nutriband Inc. and Viatris Inc.

Key Questions Answered in This Report:

  • How has the global transdermal drug delivery systems market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global transdermal drug delivery systems market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global transdermal drug delivery systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Drug Delivery Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Electroporation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radiofrequency
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Iontophoresis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Microporation
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Thermal
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Mechanical Arrays
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ultrasound
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Central Nervous System
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pain Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hormone
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Acrux Limited
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Boehringer Ingelheim International GmbH
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Hisamitsu Pharmaceutical Co. Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Lavipharm S.A.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 LEAD CHEMICAL Co. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Luye Pharma Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Nutriband Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Viatris Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials

List of Figures

  • Figure 1: Global: Transdermal Drug Delivery Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Drug Delivery Systems Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Transdermal Drug Delivery Systems Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Transdermal Drug Delivery Systems Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Transdermal Drug Delivery Systems Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Transdermal Drug Delivery Systems (Electroporation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Transdermal Drug Delivery Systems (Electroporation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Transdermal Drug Delivery Systems (Microporation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Transdermal Drug Delivery Systems (Microporation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Transdermal Drug Delivery Systems (Thermal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Transdermal Drug Delivery Systems (Thermal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Transdermal Drug Delivery Systems (Ultrasound) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Transdermal Drug Delivery Systems (Ultrasound) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Transdermal Drug Delivery Systems (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Transdermal Drug Delivery Systems (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Transdermal Drug Delivery Systems (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Transdermal Drug Delivery Systems (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Transdermal Drug Delivery Systems (Hormone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Transdermal Drug Delivery Systems (Hormone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Transdermal Drug Delivery Systems (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Transdermal Drug Delivery Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia-Pacific: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia-Pacific: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: Transdermal Drug Delivery Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: Transdermal Drug Delivery Systems Market: Breakup by Country (in %), 2022
  • Figure 81: Middle East and Africa: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: Transdermal Drug Delivery Systems Industry: SWOT Analysis
  • Figure 83: Global: Transdermal Drug Delivery Systems Industry: Value Chain Analysis
  • Figure 84: Global: Transdermal Drug Delivery Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Drug Delivery Systems Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 3: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Transdermal Drug Delivery Systems Market: Competitive Structure
  • Table 6: Global: Transdermal Drug Delivery Systems Market: Key Players